/
/
/

Natural Biocon (India) Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019
₹0₹88 L₹0₹0₹2 Cr₹1 Cr₹1 Cr₹5 Cr₹99 L₹11 Cr₹2 Cr₹3 Cr₹27 L₹42 L₹39 L₹35 L₹9 L₹24 L₹5 L₹13 L₹6 L₹2 L₹12 L₹4 L₹0₹0₹0₹0₹0₹3 Cr
₹0₹10,000₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹1 L
₹0₹88 L₹0₹0₹2 Cr₹1 Cr₹1 Cr₹5 Cr₹99 L₹11 Cr₹2 Cr₹3 Cr₹27 L₹42 L₹39 L₹35 L₹9 L₹24 L₹5 L₹13 L₹6 L₹2 L₹12 L₹4 L₹0₹0₹0₹0₹0₹3 Cr
₹1 L₹97 L₹4 L₹4 L₹2 Cr₹2 Cr₹1 Cr₹5 Cr₹89 L₹11 Cr₹2 Cr₹3 Cr₹22 L₹28 L₹33 L₹33 L₹7 L₹28 L₹4 L₹8 L₹5 L₹9 L₹3 L₹60,000₹20,000₹3 L₹60,000₹80,000₹8 L₹3 Cr
-₹1 L-₹9 L-₹4 L-₹4 L₹14 L-₹49 L₹25 L₹20 L₹10 L₹13 L₹9 L₹14 L₹5 L₹14 L₹6 L₹2 L₹2 L-₹4 L₹1 L₹5 L₹1 L-₹7 L₹8 L₹3 L-₹20,000-₹3 L-₹60,000-₹80,000-₹8 L-₹15 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10,000₹0₹10,000₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
-₹1 L-₹9 L-₹4 L-₹4 L₹14 L-₹49 L₹25 L₹20 L₹10 L₹13 L₹9 L₹14 L₹5 L₹14 L₹6 L₹2 L₹2 L-₹4 L₹1 L₹5 L₹1 L-₹7 L₹8 L₹3 L-₹20,000-₹3 L-₹60,000-₹80,000-₹8 L-₹15 L
-₹1 L-₹9 L-₹4 L-₹4 L₹14 L-₹49 L₹25 L₹20 L₹10 L₹6 L₹8 L₹14 L₹5 L₹9 L₹5 L₹2 L₹2 L-₹4 L₹1 L₹5 L₹1 L-₹7 L₹8 L₹3 L-₹20,000-₹3 L-₹60,000-₹80,000-₹8 L-₹18 L

Share Price Live Stats

Open (₹)3.42
Volume (₹)3,491.00
High (₹)3.69
Upper Circuit3.73
Low (₹)3.42
Lower Circuit3.39
Prev Close3.56
52W High (₹)7.96
Price3.52
52W Low (₹)3.04

Share Market Cap & Key Ratios Overview

M.Cap (₹)9.18 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.01
Price to Book1.20
Book Value12.36
EPS (TTM)-0.07
Face Value10.00
ROE (%)0.20

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
PREMIERENE-ANSE
CPPLUS-ANSE
AEGISLOG-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
NATURAL-XNSE
LTP
1W Low
1W High
Market cap (₹)
2886-280 (-8.84%)
2831.65
3168
3,91,876Cr
1002-12 (-1.18%)
995.50
1028.55
45,373Cr
3726.35+149.4 (4.18%)
3458.85
3784.85
43,958Cr
1277.15-12.45 (-0.97%)
1180.45
1295
43,622Cr
374+8.15 (2.23%)
343.80
376.85
28,378Cr
475+4.25 (0.90%)
465.25
491.05
15,338Cr
71.62-1.52 (-2.08%)
69.53
74.28
10,831Cr
343.5-7.5 (-2.14%)
341.30
357.45
7,658Cr
502.05-9.9 (-1.93%)
497.75
529.70
6,383Cr
112-3 (-2.61%)
110.60
116.95
579Cr
3.52-0.02 (-0.56%)
3.42
3.70
9Cr

Key Highlights of Natural Biocon (India) Ltd’s P&L

In 2025-03-31, Natural Biocon (India) Ltd reported total revenue of ₹8.35Cr, compared with ₹13.53Cr in 2024-03-31, reflecting Natural Biocon (India) Ltd turnover.

Depreciation was ₹5570 crore and finance costs were ₹8860 crore in 2025-03-31

Profit Before Tax (PBT) has been ₹5.96Lakh in 2025-03-31 as compared to ₹22.53Lakh in 2024-03-31.

Net Profit (PAT) was ₹4.46Lakh in 2025-03-31 compared with ₹15.27Lakh in 2024-03-31.

Earnings per share (EPS) were ₹0.02 in 2025-03-31, compared with ₹0.13 in 2024-03-31.